Uwe Platzbecker
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Uwe Platzbecker
Apr 24, 2024, 18:36 |
Blog
Maximilian Merz: Smells like team spirit
Maximilian Merz, Head of Early Clinical Trials at the Leipzig University, shared a post on…
Jan 16, 2024, 16:56 |
Blog
ALLG, in 2024, continues its five decades of impact - Australasian Leukaemia and Lymphoma Group
Australasian Leukaemia & Lymphoma Group shared a post on LinkedIn. "ALLG, in 2024, continues its…
Oct 25, 2023, 18:33 |
Blog
Uwe Platzbecker: He is a role model for how important patient participation and clinical trials are
Quoting Uwe Platzbecker, Head of Medical Department 1, Hematology and Cellular Therapy at Leipzig University,…
Jul 9, 2023, 09:28 |
Insight
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms - Uwe Platzbecker
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms. Specific subsets of LR-MDS…
All:
4
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube